ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes

June 10, 1988

DCBD Okays Concept For Molecular Probes In Colon Cancer, Two Other Organ Systems Generated Projects

July 4, 1986

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009